6533b7dafe1ef96bd126e1b3

RESEARCH PRODUCT

Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.

Luis ViciosoFrank HoltrupBegoña BermejoFrederick S. JonesJohannes FredebohmBegona Jimenez RodriguezMatthew B. RyderMartina AlvarezEmilio AlbaAlicia Garrido ArandaCasilda Llacer PerezCristina HernandoAna Julve ParreñoAna LluchGema Diaz CórdobaMaría Isabel Queipo-ortuño

subject

Oncologymedicine.medical_specialtymolecular profilinglcsh:MedicineDNA sequencing03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerInternal medicinemedicineMammographyLiquid biopsycirculating tumor DNA (ctDNA)GeneLymph node030304 developmental biology0303 health sciencesmedicine.diagnostic_testliquid biopsybusiness.industrylcsh:RGeneral MedicineAmpliconmedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisImmunohistochemistrybusinessearly-stage cancer

description

Circulating tumor DNA (ctDNA) has emerged as a non-invasive &ldquo

yearjournalcountryeditionlanguage
2019-08-07
10.3390/jcm8081183https://hdl.handle.net/10668/14381